SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Visible Genetics Inc.(VGIN) -- Ignore unavailable to you. Want to Upgrade?

To: Richard Haugland who wrote (240)10/16/1998 11:56:00 AM
From: Steve Lokness  Respond to of 337
 
Richard;

How does this new approved test by DIGE fit into the puzzle? biz.yahoo.com

As I understand the test, VGINF's is to test viral infection resistant strains, while DIGE's would test the CMV viral load of an infected patient. Am I at all close. If so the two test would not compete but would compliment each other. Are they similar in their technology? What do you think of DIGE's test and future?

Thanks;
Kivtan



To: Richard Haugland who wrote (240)10/20/1998 8:22:00 AM
From: Richard Haugland  Read Replies (2) | Respond to of 337
 
US Patent Issued to Visible Genetics Inc. for Combination HIV Viral Load and Genotyping Test

- VGI Patents First Integrated HIV Test that Quantifies Viral Levels and Genotypes with Faster Results and Lower Costs -

biz.yahoo.com


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News